Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. - Wikidata - wikimedia - TriplyDB

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.

http://www.wikidata.org/entity/Q36422686

about

Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides Quantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic review Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.Interaction of daptomycin with lipid bilayers: a lipid extracting effect The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol.Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides.Necrosis of Staphylococcus aureus by the Electrospun Fe- and Ag-Doped TiO2 Nanofibers.LysPGS formation in Listeria monocytogenes has broad roles in maintaining membrane integrity beyond antimicrobial peptide resistance.Genetic basis for daptomycin resistance in enterococci.Epithelial microvilli establish an electrostatic barrier to microbial adhesion High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance.Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content Mitigation of Staphylococcus aureus-mediated surgical site infections with ir photoactivated TiO2 coatings on Ti implants.Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides.Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides.Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.Genetic basis for in vivo daptomycin resistance in enterococci.Mechanisms of antibiotic resistance in enterococci.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.

P2860

Q26744785-9494F344-1B88-4093-A2CE-FB7BDA90BCAF Q26796165-537E71A6-BC36-4357-8BDC-5734B5528218 Q26863225-210E853D-E935-4C6A-A828-E18D6BD46562 Q28072687-C7E72178-ABDA-4A3F-8B0D-F92E65352FF6 Q28740293-D22D9C2E-468E-4097-8587-A84B3D3E71DE Q30452801-7853ABCC-B434-4B0B-9B3E-297EDC502EC6 Q30586516-A4131DDE-CA6D-463E-8D69-74D7F05697A9 Q30886130-E18E3C18-8DE9-411C-BEB1-7101A2E42271 Q31131146-BEBC9A15-05E5-4C37-B979-FBBCFF334885 Q33507347-B85B3580-8B83-4369-8533-CFD472F39C4F Q33755855-D1127B92-6889-40B2-AB3D-14D6B129398B Q33776656-72395ADA-0D35-480F-B94F-D597599D6CD0 Q33779111-11DFB466-51E7-4C70-B8FA-BD01F4E59752 Q33876255-722042BE-B96E-4B8A-A958-5640A9B02AD6 Q33899795-ED6E29C7-6E04-4A33-B19F-EB3511E51D08 Q33911941-E408AFC4-AFFD-4C23-B7A0-FC343BCB9F6B Q33939055-B2AA3442-8CC3-47AF-9A05-3E66CFA5F516 Q34045273-EB506458-1918-483B-A925-38CDAB7DEEE8 Q34045376-7E1C7366-59B9-4EA9-AC2D-13057EF90CE9 Q34151075-B7A769FA-949B-458F-8F76-69E0DF561FDA Q34405922-3711136A-7CC5-400C-8403-46C8A016492C Q34489407-984DE64B-9FA4-47F0-8752-011D8F01C5D1 Q34529075-710DA7B8-AEFF-46C7-B97A-F0C72A776526 Q34549813-AA1CA391-86E2-4D6B-A875-DDC33EADDA3B Q34595733-E43163D0-206E-4BA6-89F9-D296AA249A6E Q34597770-4F3D9FBA-D664-4C83-B19B-6C85E476668A Q34648042-B8F9C361-42F9-4D07-AA31-E48DD0B8669A Q34779009-D149DFE5-B99C-4506-A8CD-A8A0ECDF3C3B Q34932588-F7B4615F-CD15-41A3-A315-2CC624DCE835 Q35096905-28CD1649-AD82-4B43-9315-6B7D76DF7AFB Q35139449-7766F3D4-BF79-47D5-8F73-A88292DEE669 Q35191555-5240692C-B38F-4F27-BE64-DDCEAAAF7E60 Q35256159-59BDDF89-01EF-4649-A1E4-8549360F2262 Q35385568-5C290F0C-5E1F-46E3-A6F0-3696052F8708 Q35473516-E79479A0-8513-4958-BC36-30794FEACCEF Q35499202-77D0E05D-6CAE-4D66-995F-581189631B8D Q35610646-E32BCD14-2969-4551-9296-DA65EBFF7BB7 Q35619094-B783E6F4-4F43-43D0-8E44-5A86962A69ED Q35665343-4B927482-3078-4A5C-A629-294A676898A1 Q35689222-A8F42825-7DFA-4EF5-8F45-AB2C30B37F8E

P2860

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.

http://www.wikidata.org/entity/Q36422686

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Failures in clinical treatment ...... d asymmetry, and drug binding.

@ast

Failures in clinical treatment ...... d asymmetry, and drug binding.

@en

type

label

Failures in clinical treatment ...... d asymmetry, and drug binding.

@ast

Failures in clinical treatment ...... d asymmetry, and drug binding.

@en

prefLabel

Failures in clinical treatment ...... d asymmetry, and drug binding.

@ast

Failures in clinical treatment ...... d asymmetry, and drug binding.

@en

P1433

Q36422686-231D86F8-4EBD-42FA-BD65-86BD9FAF88AF

P1476

Q36422686-BD3E8C74-503C-43A6-9B3E-982704E97B77

P2093

Q36422686-261A6EFB-F6C5-4778-8C28-2F42DABF18BC

Q36422686-28D7E141-9FC2-4F46-ADC1-C86C79780896

Q36422686-4FAA18D1-D9AD-4CDD-A593-5F244353B2DA

Q36422686-786081B7-36EB-4148-8309-F10AAD711CE0

Q36422686-9C48EF87-CACD-4975-8F12-77F7DBAF4B43

Q36422686-CC45B541-8B3A-425A-95BC-DB5B6CE0B9AC

Q36422686-D1C46BC0-AF86-409E-AA81-E849FF4BB89F

Q36422686-DB08D7D3-85B8-47C6-B3B0-2EBACB64A58A

P2860

Q36422686-0A936428-FBC0-4EA4-A47C-8C9EA0EA2FBD

Q36422686-133B1BCF-34D6-439A-AB14-62DD889360E7

Q36422686-139D4F2A-837F-42F6-89D8-3AD5925F06DF

Q36422686-17510E78-E89B-4A0A-9969-B57C5EAA433C

Q36422686-17900CA4-67D7-4BCC-A1A7-1C966BF84329

Q36422686-1F21AD09-840F-4B02-8B0C-9417BACF8B86

Q36422686-227B93C6-EE5F-4ACD-AB54-5C71561CEBEA

Q36422686-28BDE300-AB87-4A0B-9257-EF38DD63C74E

Q36422686-2B661691-046C-494B-A84F-16D7E2698B3F

Q36422686-30DD3EAC-88B4-4438-8694-CFA75C38E984

P304

Q36422686-4927AE60-947C-49E1-B2F5-0603E05B40F8

P31

Q36422686-1CC3AE6C-6D80-4B6B-97D2-73F6AC66C0C9

P356

Q36422686-93CB2AB9-4D48-412B-8A0F-0D49A9C3AD01

P407

Q36422686-0B5EA388-30EE-45DA-A999-D795E88C3CC3

P433

Q36422686-BEBCF0FB-C28E-4F91-A20E-4082C2EFE834

P478

Q36422686-0608F777-B9C0-477B-BF8E-61EFE08A9FD2

P50

Q36422686-F4D6EC04-0DB8-45A4-B632-70C31779634B

P577

Q36422686-29605F81-E514-4510-B9B5-A33F061358AC

P5875

Q36422686-DD550D75-BAD8-4813-8648-6A639D240E2B

P698

Q36422686-ABB6AE90-CD4B-4C94-975A-478EE08C3DE0

P932

Q36422686-6D4344DC-BEC0-4FB3-A52C-D174E591D41B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Failures in clinical treatment ...... d asymmetry, and drug binding.

@en

P2093

Arnold S Bayer

http://www.w3.org/2001/XMLSchema#string

George Sakoulas

http://www.w3.org/2001/XMLSchema#string

Hans-Georg Sahl

http://www.w3.org/2001/XMLSchema#string

Michael R Yeaman

http://www.w3.org/2001/XMLSchema#string

Richard A Proctor

http://www.w3.org/2001/XMLSchema#string

Soo-Jin Yang

http://www.w3.org/2001/XMLSchema#string

Tiffanny Jones

http://www.w3.org/2001/XMLSchema#string

Yan Q Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of peptides with basic residues to membranes containing acidic phospholipids

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity

A simple method for the isolation and purification of total lipides from animal tissues

The conducting form of gramicidin A is a right-handed double-stranded double helix

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.

Gramicidin D conformation, dynamics and membrane ion transport.

Membrane permeabilization by thrombin-induced platelet microbicidal protein 1 is modulated by transmembrane voltage polarity and magnitude

Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus.

In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action.

P304

269-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00719-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Schrenzel

P577

2007-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5890483

http://www.w3.org/2001/XMLSchema#string

P698

17954690

http://www.w3.org/2001/XMLSchema#string

P932

2223911

http://www.w3.org/2001/XMLSchema#string